Teddi Mellencamp Arroyave Says She Has Another Year of Immunotherapy
teddi mellencamp arroyave said she has at least another year of immunotherapy treatment and is going for another round of scans on Tuesday. The update came through her Instagram Story, a little over a year after her brain surgery, and keeps her Stage 4 cancer monitoring on a tight medical schedule.
"Going for another round and scans on Tuesday," she wrote, pairing the next step with the longer treatment runway. She also told followers, "A lot of these types of messages came through and I just want everyone to know how grateful I am every day for the love and support you continue to send my way. It does not go unnoticed."
Another year on immunotherapy
At least another year of immunotherapy means the treatment plan is not closing out any time soon. Mellencamp has said she is still monitoring her health with her doctors, and that makes the Tuesday scans the next concrete check on how the current approach is holding up.
That timeline also fits with the way she has described her recovery in recent posts. On April 29, she said, "It's not lost on me how much my hair has grown since the brain surgeries," putting a visible sign of recovery alongside the still-active cancer treatment.
April 29 and April 30 updates
On April 29, Mellencamp also posted, "My question is, now what?" and said, "The hair is too long for the wigs, and I'm sick of the wigs." A day later, she said Cruz Arroyave, her 11-year-old son, tried to help style her hair, while Slate Arroyave and Dove Arroyave also tried to fix it.
"This might be tough, not gon' lie bruh," she said in the video showing Cruz helping with her hair. In the caption, she added, "Cruz thought he could help with my hair sitch, but really all he did was make me look like one of the Paul brothers."
Tuesday scans on deck
The Tuesday scan round is the clearest next marker in her cancer journey, because it turns a broad treatment update into a specific medical checkpoint. For anyone following her health closely, that is the number to watch: another year of immunotherapy, then new scans, then the next readout from her doctors.
